Literature DB >> 9401490

Disseminated intravascular coagulopathy as an adverse reaction to intermittent rifampin schedule in the treatment of leprosy.

C S Souza1, F L Alberto, N T Foss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9401490

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN： 0148-916X


× No keyword cloud information.
  4 in total

Review 1.  Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin.

Authors:  Thomas C Havey; Christine Cserti-Gazdewich; Michelle Sholzberg; Jay S Keystone; Wayne L Gold
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

Review 2.  Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients.

Authors:  Rossilene Conceição da Silva Cruz; Samira Bührer-Sékula; Maria Lúcia F Penna; Gerson Oliveira Penna; Sinésio Talhari
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896

3.  Rifampicin-induced disseminated intravascular coagulation in pulmonary tuberculosis treatment: A case report and literature review.

Authors:  Guo Chen; Jian-Qing He
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

4.  Rifampicin-Induced Fever in a Patient with Brucellosis: A Case Report.

Authors:  Mesut Yilmaz; Canan Yasar; Selda Aydin; Okan Derin; Bahadir Ceylan; Ali Mert
Journal:  Drug Saf Case Rep       Date:  2018-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.